In our study, we found that MIP-1α, MIP-1β and MIP-2 exhibit a better sensitivity (89.9 %, 97.7 % and 88.0 %) and specificity (83.8 %, 82.5 % and 82.5 %) for lung cancer diagnosis. This evidence concerns the gene CCL4 and lung cancer.